1. Home
  2. IMMX vs AP Comparison

IMMX vs AP Comparison

Compare IMMX & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMX
  • AP
  • Stock Information
  • Founded
  • IMMX 2014
  • AP 1929
  • Country
  • IMMX United States
  • AP United States
  • Employees
  • IMMX N/A
  • AP N/A
  • Industry
  • IMMX Medicinal Chemicals and Botanical Products
  • AP Fluid Controls
  • Sector
  • IMMX Health Care
  • AP Industrials
  • Exchange
  • IMMX Nasdaq
  • AP Nasdaq
  • Market Cap
  • IMMX 61.1M
  • AP 62.7M
  • IPO Year
  • IMMX 2021
  • AP N/A
  • Fundamental
  • Price
  • IMMX $2.75
  • AP $3.43
  • Analyst Decision
  • IMMX Strong Buy
  • AP
  • Analyst Count
  • IMMX 1
  • AP 0
  • Target Price
  • IMMX $7.00
  • AP N/A
  • AVG Volume (30 Days)
  • IMMX 208.2K
  • AP 64.1K
  • Earning Date
  • IMMX 08-11-2025
  • AP 08-11-2025
  • Dividend Yield
  • IMMX N/A
  • AP N/A
  • EPS Growth
  • IMMX N/A
  • AP N/A
  • EPS
  • IMMX N/A
  • AP 0.22
  • Revenue
  • IMMX N/A
  • AP $412,355,000.00
  • Revenue This Year
  • IMMX N/A
  • AP N/A
  • Revenue Next Year
  • IMMX N/A
  • AP N/A
  • P/E Ratio
  • IMMX N/A
  • AP $16.71
  • Revenue Growth
  • IMMX N/A
  • AP N/A
  • 52 Week Low
  • IMMX $1.26
  • AP $1.26
  • 52 Week High
  • IMMX $3.20
  • AP $3.99
  • Technical
  • Relative Strength Index (RSI)
  • IMMX 54.63
  • AP 54.81
  • Support Level
  • IMMX $2.63
  • AP $3.25
  • Resistance Level
  • IMMX $3.20
  • AP $3.95
  • Average True Range (ATR)
  • IMMX 0.23
  • AP 0.28
  • MACD
  • IMMX -0.03
  • AP 0.02
  • Stochastic Oscillator
  • IMMX 23.73
  • AP 44.55

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

Share on Social Networks: